|
|||||
|
|
Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast,prostate, lung and colon |
|
| Authors: | Liv B. Gansmo Stian Knappskog Pål Romundstad Kristian Hveem Lars Vatten Per E. Lønning |
| Affiliation: | 1. Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway;2. Department of Oncology, Haukeland University Hospital, Bergen, Norway;3. Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway |
| Abstract: | |
| Keywords: | MDM2 SNP309 SNP309 cancer risk |